← Back to Search

Water Dosing for Orthostatic Hypotension

N/A
Waitlist Available
Led By Satish R Raj, MD MSCI
Research Sponsored by Satish R. Raj
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18-80 years
Orthostatic hypotension (fall in BP>20/10 mmHg)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2nd intervention
Awards & highlights

Study Summary

This trial is testing whether drinking water will help blood pressure in patients with low blood pressure when standing up, when they have had a lot to drink beforehand.

Who is the study for?
This trial is for adults aged 18-80 with orthostatic hypotension, which means their blood pressure drops significantly when standing up. They should have previously shown a blood pressure increase after drinking water in other studies. Pregnant individuals cannot participate.Check my eligibility
What is being tested?
The study investigates the effect of two different doses of water on blood pressure in patients with orthostatic hypotension. It aims to determine if the pressor (blood-pressure raising) response to water diminishes when a full dose is taken earlier.See study design
What are the potential side effects?
Drinking high or low doses of water typically does not cause side effects; however, it may lead to discomfort from bloating or stomach fullness and very rarely might contribute to changes in electrolyte balance.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 80 years old.
Select...
My blood pressure drops significantly when I stand up.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2nd intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2nd intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
blood pressure
Secondary outcome measures
heart rate

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
16 oz water in AM
Group II: 2Active Control1 Intervention
water 1 oz in AM

Find a Location

Who is running the clinical trial?

Satish R. RajLead Sponsor
6 Previous Clinical Trials
510 Total Patients Enrolled
1 Trials studying Orthostatic Hypotension
20 Patients Enrolled for Orthostatic Hypotension
Satish R Raj, MD MSCIPrincipal InvestigatorVanderbilt University Medical Center
19 Previous Clinical Trials
1,406 Total Patients Enrolled
2 Trials studying Orthostatic Hypotension
20 Patients Enrolled for Orthostatic Hypotension

Media Library

water high dose Clinical Trial Eligibility Overview. Trial Name: NCT00580996 — N/A
Orthostatic Hypotension Research Study Groups: 1, 2
Orthostatic Hypotension Clinical Trial 2023: water high dose Highlights & Side Effects. Trial Name: NCT00580996 — N/A
water high dose 2023 Treatment Timeline for Medical Study. Trial Name: NCT00580996 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must potential participants fulfill to qualify for this research endeavor?

"This medical experiment is actively searching for 20 individuals between 18 and 80 years of age who suffer from orthostatic hypotension. Furthermore, candidates must have shown a pressor response to water in past studies."

Answered by AI

Does this research initiative allow for participation from those over the age of forty?

"This trial mandates that all participants be 18 years of age or older, with no upper limit for eligibility; the maximum permitted age is 80."

Answered by AI

Is there still the opportunity to join this experiment?

"According to clinicaltrials.gov, this experiment is not accepting new participants at present. The trial was initially uploaded on July 1st 2006 and last updated September 12th 2022; however, there are 110 other studies currently recruiting patients."

Answered by AI
~2 spots leftby Dec 2025